findmyKOL
Clinical trialNCT05674786RecruitingInterventional

Vestibular Implantation to Treat Adult-Onset Bilateral Vestibular Hypofunction

SponsorJohns Hopkins UniversityEnrollment8Aminoglycoside OtotoxicityBilateral Vestibular Deficiency (BVD)Bilateral Vestibular HypofunctionBilateral VestibulopathyGentamicin OtotoxicityLabyrinth Diseases+3 more conditions
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Johns Hopkins School of Medicine

    Baltimore, Maryland, United States

    Charles C Della Santina MDPhD (Lead Surgeon; CEO Labyrinth Devices LLC)John P Carey MD (Independent/Nonconflicted IRB Protocol PI)
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
28 Feb 2023
Primary completion
31 Dec 2026
Completion
31 Mar 2027
Last update posted
12 Jan 2026
Registered enrollment
8
Registry id
NCT05674786

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.